John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Tilray
TLRY
$660M
| $423K | ﹤0.01% |
+64,323
| New | +$595K |
|
2527
Innovative Industrial Properties
IIPR
$1.57B
| $419K | ﹤0.01% |
+7,744
| New | +$536K |
|
|
FOVL
2528
DELISTED
iShares Focused Value Factor ETF
FOVL
| $418K | ﹤0.01% |
+6,000
| New | +$429K |
|
|
PBPB
2529
DELISTED
Potbelly
PBPB
| $417K | ﹤0.01% |
43,874
-967
| -2% | -$10.7K |
|
2530
Artisan Partners
APAM
$3.04B
| $416K | ﹤0.01% |
10,644
-63,842
| -86% | -$2.7M |
|
2531
Invesco Pharmaceuticals ETF
PJP
$536M
| $416K | ﹤0.01% |
+4,800
| New | +$409K |
|
2532
Kodak
KODK
$929M
| $415K | ﹤0.01% |
65,683
-8,527
| -11% | -$59.2K |
|
2533
First Trust Water ETF
FIW
$1.9B
| $413K | ﹤0.01% |
+4,100
| New | +$424K |
|
2534
Blue Owl Capital
OBDC
$5.59B
| $412K | ﹤0.01% |
28,127
-672,479
| -96% | -$10.1M |
|
|
NPB
2535
Northpointe Bancshares
NPB
$587M
| $412K | ﹤0.01% |
+28,539
| New | +$409K |
|
2536
Virco
VIRC
$95M
| $412K | ﹤0.01% |
43,519
+2,855
| +7% | +$29.7K |
|
2537
Universal Electronics
UEIC
$57M
| $411K | ﹤0.01% |
67,219
-17,317
| -20% | -$152K |
|
2538
Commercial Vehicle Group
CVGI
$124M
| $411K | ﹤0.01% |
357,080
+131,432
| +58% | +$254K |
|
|
DCH
2539
Dauch Corp
DCH
$1.52B
| $408K | ﹤0.01% |
100,346
-84,474
| -46% | -$433K |
|
|
ASM
2540
Avino Silver & Gold Mines
ASM
$1.27B
| $406K | ﹤0.01% |
220,403
-13,674
| -6% | -$18.6K |
|
|
XYZ
2541
Block Inc
XYZ
$49.4B
| $405K | ﹤0.01% |
7,446
-298
| -4% | -$22.2K |
|
|
BBUC
2542
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.79B
| $402K | ﹤0.01% |
+15,104
| New | +$384K |
|
2543
VanEck Gold Miners ETF
GDX
$32.7B
| $402K | ﹤0.01% |
8,739
-3,842,461
| -100% | -$155M |
|
2544
ProQR Therapeutics
PRQR
$322M
| $402K | ﹤0.01% |
301,912
-81,222
| -21% | -$173K |
|
2545
Vicor
VICR
$8.95B
| $401K | ﹤0.01% |
8,563
+11
| +0.1% | +$583 |
|
2546
Neuropace
NPCE
$484M
| $399K | ﹤0.01% |
32,432
+6,286
| +24% | +$78.7K |
|
2547
Nkarta
NKTX
$194M
| $398K | ﹤0.01% |
216,438
+12,675
| +6% | +$26K |
|
|
SRG
2548
Seritage Growth Properties
SRG
$119M
| $397K | ﹤0.01% |
122,974
-82,898
| -40% | -$304K |
|
2549
Arcturus Therapeutics
ARCT
$445M
| $396K | ﹤0.01% |
37,355
+9,795
| +36% | +$155K |
|
2550
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$744M
| $394K | ﹤0.01% |
+6,000
| New | +$386K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.